Fundraising Fox

Cerevasc

Auburndale, US · Founded 2020 · Delaware corporation · 37 employees on LinkedIn · 1 known investors

Find your way into Cerevasc

9 people in our graph share verified history with the Cerevasc team — schools, employers, funds. One of them is your warm intro.

Andrew Gasparunlockedknows Daniel Levangie · together at Northeastern University (overlapped)
×3knows the team · via Northeastern University
knows the team · via Cerevasc
×4knows the team · via Keystone Dental

CereVasc is developing the eShunt System, a minimally invasive device intended to treat communicating hydrocephalus in children and adults as an alternative to invasive neurosurgical procedures. The company operates in the medical device sector for neurological conditions.

BiotechHealthtechMedical Devices

Founders & leadership

Cerevasc was founded in 2020 by Carl Heilman and Daniel Levangie.

CH
Carl HeilmanCo-founder
DLDaniel Levangie
Daniel LevangieinCo-founder · President & CEODaniel Levangie is an experienced medical device executive who previously served as Chief Executive Officer of Dune Medical Devices and co-founded Constitution Medical Investors, a Boston-based product development firm acquired by Roche Diagnostics in 2013. He held multiple senior leadership roles at Cytyc Corporation before its acquisition by Hologic in 2007, and earlier worked in sales and management positions at Abbott Laboratories; he is a graduate of Northeastern University.
LTLeslie Teso-Lichtman
Leslie Teso-LichtmaninSVP, Chief Financial Officer & Treasurer2020–2024
FC
Frederick CalloriNamed on SEC filing
PS
Patrick SullivanNamed on SEC filing
AL
Aaron LevangieNamed on SEC filing

Board

CG
Chris GarabedianBoard director

Investors · 1

Bain Capital Life SciencesBoston

Reported raises · per SEC filings

Form D private placements

$11.1M disclosed across 1 round · 2020

▶$11.1MraisedJun 2020 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frederick CalloriDirector
  • Chris GarabedianDirector
  • Patrick SullivanDirector
  • Aaron LevangieExecutive Officer
  • Carl HeilmanDirector
  • Daniel LevangieExecutive Officer, Director
  • Leslie Teso-LichtmanExecutive Officer
Offering amount
$32.5M
Amount sold
$11.1M
First sale
May 2020
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap
Rf Surgical61 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Medscape42 shared keywordsMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies competing with Cerevasc for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Cerevasc do?
CereVasc is developing the eShunt System, a minimally invasive device intended to treat communicating hydrocephalus in children and adults as an alternative to invasive neurosurgical procedures. The company operates in the medical device sector for neurological conditions.
Who founded Cerevasc?
Cerevasc was founded by Carl Heilman, Daniel Levangie in 2020.
Who are Cerevasc's investors?
Cerevasc's investors include Bain Capital Life Sciences.
How much funding has Cerevasc raised?
Cerevasc has disclosed $11.1M raised across 1 round.
Where is Cerevasc headquartered?
Cerevasc is headquartered in Auburndale, US.